There are 110 papers on Helicobacter pylori infection in aging research: 9 trials and 57 observational studies in people, 2 in animals, 38 reviews.
110 papers study it39 more mention it17 findings
10 new papers in 30 daysSee all 149 papers on Helicobacter pylori infection
At a glance
Human studies associate Helicobacter pylori infection with age, platelet-to-HDL cholesterol ratio and previous upper gastrointestinal endoscopy; a study in women links infection to gastric cancer burden. A human study finds no infection effect from awareness of its gastric cancer link.
17 findings in 16 papers from 2005 to 2026, 7 of them since July 2026
“a higher fracture risk was observed in the delayed/failed HP eradication group (HR: 1.37; 95% CI: 1.21-1.56).”
- Human trial9
- Humans57
- Animals2
- In silico3
Interventions
1Acetylcysteine
downin humans1
1 study
Acetylcysteine
downin humans1
Acetylcysteine decreases Helicobacter pylori infection in humans with clarithromycin and lansoprazole dual therapy (50.0% vs 23.3%).
“The difference between the AC group and the control group was statistically significant (P = 0.034).”
Human trialwith clarithromycin and lansoprazole dual therapy400 mg tid10 daysn = 58
Effect of N-acetyl cysteine on Helicobacter pylori
Southern medical journal
Upstream
1Helicobacter pylori-gastric cancer awareness
no changein humans1OR 0.58
1 study
Helicobacter pylori-gastric cancer awareness
no changein humans1OR 0.58
Helicobacter pylori-gastric cancer awareness was not clearly linked with Helicobacter pylori infection in humans (14.8% vs. 22.9%; OR 0.58).
“Current infection was less frequent among those who were aware (14.8% vs. 22.9%; OR 0.58, p = 0.13), although this difference was not statistically significant.”
Humansn = 265
Journal of cancer education : the official journal of the American Association for Cancer Education
Associations
15Platelet-to-high-density lipoprotein cholesterol ratio
upin humans1OR 1.1
1 study
Platelet-to-high-density lipoprotein cholesterol ratio
upin humans1OR 1.1
Platelet-to-high-density lipoprotein cholesterol ratio is associated with Helicobacter pylori infection in humans (fully adjusted) (OR 1.10, 95% CI 1.05-1.15).
“PHR was positively associated with Helicobacter pylori seropositivity after full adjustment (OR, 1.10; 95% CI, 1.05-1.15; P”
Humansfully adjusted
Clinics and research in hepatology and gastroenterology
More on Platelet-to-high-density lipoprotein cholesterol ratio
Screening
upin humans1
1 study
Screening
upin humans1
Screening is associated with Helicobacter pylori infection in humans (18.0% (58/323)).
“Among 323 participants screened, 58 (18.0%) had active H. pylori infection”
Humans6 monthsn = 323
Health promotion practice
Gastric cancer burden
upin humans1
1 study
Gastric cancer burden
upin humans1
Helicobacter pylori infection is associated with gastric cancer burden in humans.
“in whom the Human Development Index and H. pylori prevalence were also relevant.”
Humansfemales
Journal of cancer policy
Age
upin humans1OR 2.23
1 study
Age
upin humans1OR 2.23
Age is associated with Helicobacter pylori infection in humans (OR 2.23, 95% CI 1.48-3.36).
“significantly higher in patients aged ≥50 years compared to younger patients (26.2% vs. 13.7%; p < 0.001; OR: 2.23; 95% CI = 1.48-3.36).”
Humansn = 775
Journal of clinical medicine
Previous upper gastrointestinal endoscopy use
upin humans1
1 study
Previous upper gastrointestinal endoscopy use
upin humans1
Helicobacter pylori infection is associated with previous upper gastrointestinal endoscopy use in humans (aOR 2.29, 95% CI 1.70-3.08).
“Previous UGE use was more common among participants with self-reported H. pylori infection (adjusted odds ratio [aOR] 2.29, 95% CI 1.70-3.08)”
Humansn = 1,911
Frontiers in public health
Hospital worker
upin humans1+17%
1 study
Hospital worker
upin humans1+17%
Helicobacter pylori infection is associated with hospital worker in humans (occupational health surveillance screening) (16.6%).
“H.pylori prevalence was 16.6%.”
Humansoccupational health surveillance screeningn = 435
A real-world workplace-based screening for Helicobacter pylori infection: the HPOS study
Cancer causes & control : CCC
Bone fracture
upin humans1HR 1.37
1 study
Bone fracture
upin humans1HR 1.37
Helicobacter pylori infection is linked with a higher risk of bone fracture in humans (delayed/failed eradication compared with HP-negative group) (HR: 1.37; 95% CI: 1.21-1.56).
“a higher fracture risk was observed in the delayed/failed HP eradication group (HR: 1.37; 95% CI: 1.21-1.56).”
Humansdelayed/failed eradication compared with HP-negative group
Journal of gastroenterology and hepatology
Pepsinogen I/II ratio
downin humans1
1 study
Pepsinogen I/II ratio
downin humans1
Helicobacter pylori infection is associated with pepsinogen I/II ratio in humans (β -2.75 (95% CI -3.33 to -2.17)).
“Factors such as H. pylori-positive (including prior eradication), high salt intake, and frequent fruit consumption were significantly associated with baseline serum PGR levels nationwide, with β value (95%CI) being - 2.75 (-3.33, -2.17)”
Humansn = 2,902
Scientific reports
Lumbar spine bone mineral density
downin reviews1
1 study
Lumbar spine bone mineral density
downin reviews1
Helicobacter pylori infection is associated with lumbar spine bone mineral density in older males.
“a correlation was found between H. Pylori infections and reduced lumbar spine bone mineral density in older males”
Reviewin older malesbonemales
Exploring osteomicrobiology: A narrative review of the gut-bone axis in osteoporosis
Irish journal of medical science
Socioeconomic status disadvantage
upin humans1OR 2.2
1 study
Socioeconomic status disadvantage
upin humans1OR 2.2
Socioeconomic status disadvantage is associated with Helicobacter pylori infection in young adulthood (OR 2.2, 95% CI 1.7-2.9).
“persistent SES disadvantage was associated with higher odds of CMV, HSV-1, and H. Pylori infection (e.g. H. Pylori OR = 2.2, 95 % CI: 1.7, 2.9)”
Humansin young adulthood
Social science & medicine (1982)
All 15Fewer
Trial sponsors
Company1 trialPhase 4364 people
Company1 trialPhase 4123 people
Company2 trialsPhase 31,061 people
Company2 trialsPhase 3634 people
Company1 trialPhase 3455 people
Company1 trialPhase 360 people
Company1 trialPhase 132 people
Company1 trialPhase 128 people
Funding
2 grants since 2022National Cancer Institute$663KGouvernement du Canada | Canadian Institutes of Health Research
How this record changed
Summary written from the findings.